Sense Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, announced the initiation of a multicenter pivotal trial to evaluate the safety and efficacy of a non-invasive brain scanner to monitor intracranial hemorrhage (ICH) in an acute hospital setting.

Sense Diagnostics is honored to be named Business Center Client of the Year by HCDC, Inc, an economic development organization that runs a technology business incubator, is an SBA lender, and is the Economic Development Office for Hamilton County, Ohio.

Congratulations to Geoffrey Klass, CEO of Sense Neuro Diagnostics on being selected as an Innovation Leader at the LSI 2021 Emerging Medtech Summit. For the second year in a row, Geoff Klass will be presenting to an exceptional group of investors and strategics.

Sense Neuro Diagnostics co-founder and CTO Dr. George Shaw, MD, will present clinical findings at the Society for Academic Emergency Medicine’s 2021 virtual meeting in May. The abstract accepted for presentation, “Pilot study of a non-invasive RF method to determine stroke subtype,” details Sense’s first-in human stroke differentiation study.